Top Markets
#1 DogBull DogBull +108.63%
#2 Siacoin Siacoin +66.67%
#3 MarsCoin MarsCoin +60.42%
#4 ADO Protocol ADO Protocol +53.58%
#5 The Bitcoin Bull The Bitcoin Bull +31.93%
#6 Ontology Gas Ontology Gas +22.49%
#7 Akedo Akedo +12.84%
#8 UnifAI Network UnifAI Network +11.47%
#9 AI XOVIA AI XOVIA +11.39%
#10 Cryptopia Cryptopia +10.51%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Zhejiang Taimei Medical Technology Co., Ltd. Zhejiang Taimei Medical Technology Co., Ltd.

Zhejiang Taimei Medical Technology Co., Ltd.

2576
Classement en actions #15029
Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in... Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, specializes in delivering sophisticated digital operational platforms specifically designed for the biopharmaceutical industry across the country. The company's core offering is TrialOS, a comprehensive digital collaboration platform that seamlessly integrates all participants throughout the drug development and research lifecycle. This ecosystem effectively links hospitals, pharmaceutical firms, external service providers, regulatory bodies, and patients, among other key industry stakeholders. Its extensive portfolio of software solutions caters to various critical aspects of clinical research and drug development. For streamlining clinical trial operations, Taimei Medical provides tools like eCooperate, which optimizes management systems and leverages big data for informed decision-making. Other related offerings include eArchives for managing master files, eCollect for electronic data capture, eCollege for training administration, eQuality for electronic audit processes, and eBalance for interactive web-based responses. Innovations such as eVisit Patient Reported Outcomes are designed to enhance patient data input and accuracy, while eTime supports project time management, and eImage facilitates medical image interpretation. Furthermore, the company supplies specialized software tailored for hospitals and Good Clinical Practice (GCP) sites. These include eTrial for managing Phase I wards, eSite and NomenCTMS for comprehensive clinical trial management at study sites, and intelligent platforms like GCP-X and Intelligent Investigator. Solutions such as eScreening assist with subject information management and deduplication, while IIT-EDC and the Investigator-Initiated Clinical Trial Management System support investigator-initiated studies and their associated data management. In the crucial domain of drug safety, the company offers robust pharmacovigilance software solutions. This includes both global and intelligent eSafety systems, alongside the SAE Manager for efficient communication and management of critical safety data during clinical trials. Complementing these, Zhejiang Taimei also develops marketing software and a variety of other digital innovation solutions.
Prix de l'action
$0.67033345
Capitalisation boursière
$377.97M
Changement (1 jour)
-3.68%
Changement (1 an)
5.38%
Pays
CN
Échange Zhejiang Taimei Medical Technology Co., Ltd. (2576)

Catégorie

Technology
Ratio P/E pour Zhejiang Taimei Medical Technology Co., Ltd. (2576)
Ratio P/E au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Zhejiang Taimei Medical Technology Co., Ltd., le ratio P/E actuel (TTM) est de 0. À la fin de l’année 2026, le P/E de l’entreprise était de 0.
Historique du ratio P/E pour Zhejiang Taimei Medical Technology Co., Ltd. de 2026 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
Pas assez de données pour les dates fournies.
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
SAP SE SAP SE
SAP SE
SAP.DE
 27.13 -
DE
Salesforce, Inc. Salesforce, Inc.
Salesforce, Inc.
CRM.US
 23.41 -
US
Shopify Inc. Shopify Inc.
Shopify Inc.
SHOP.TO
 - -
CA
Uber Technologies, Inc. Uber Technologies, Inc.
Uber Technologies, Inc.
UBER.US
 16.34 -
US
ServiceNow, Inc. ServiceNow, Inc.
ServiceNow, Inc.
NOW.US
 91.92 -
US
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.